ALAB

Astera Labs dropped 16.5% in an AI sector sell-off despite having no debt and $1.25 billion in cash. The author recommends buying the dip, citing the company's recent launches of PCIe 7 Aries chips and Orion rack-scale design, along with upcoming Q3 earnings on November 3rd. However, the stock trades at high multiples and depends on a few large customers, making it volatile.

While Micron Technology has surged 350% over the past year, the article argues that three alternative memory stocks offer better value and growth prospects: SK Hynix delivers higher sequential growth and lower valuation, Sandisk shows faster expansion with long-term customer contracts, and Astera Labs provides exposure to AI infrastructure with accelerating guidance.

Astera Labs (ALAB) has outperformed Cisco (CSCO) year-to-date with an 81.5% gain versus 42.6%, but Cisco is rated as offering greater upside potential due to stronger AI infrastructure momentum and robust networking demand. While ALAB benefits from strong adoption of its PCIe 6 products and expanding AI connectivity portfolio, rising operating expenses and competition are concerns. Cisco carries a Zacks Rank #2 (Buy) versus ALAB's Rank #3 (Hold).

The article compares two semiconductor companies powering AI data centers: Astera Labs, a high-speed connectivity specialist with 115% revenue growth but high customer concentration (70% from one customer), and Marvell Technology, a broader semiconductor provider with 42% growth, lower valuation multiples, and confidence in reaching $70-90 billion in revenue by 2031. The author recommends Marvell due to its more attractive valuation, diversified product portfolio, and long-term growth visibility despite both companies facing customer concentration and geopolitical risks.

Credo Technology Group has launched the Short-Reach Micro-Emitter Optics (SRMO) Workstream within the Open Compute Project to establish specifications for high-speed data center interconnects. The initiative targets 2027 OCP approval and aims to drive adoption of micro-emitter optics technology. Credo faces competition from Marvell Technology and Astera Labs in the optical connectivity market as AI infrastructure expands.

Astera Labs (ALAB) declined 1.39% to $342.21, underperforming the broader market which gained 0.6%. Despite the daily drop, the stock has gained 21.97% year-to-date, outpacing the tech sector.

The company is expected to report earnings on November 3, 2026, with anticipated EPS of $1.19 (up 142.86% YoY) and revenue of $550.39 million (up 138.71% YoY). ALAB currently holds a Zacks Rank #3 (Hold) with a Forward P/E of 87.31, significantly above its industry average of 20.7.

Astera Labs announced Aries 7, the industry's first PCIe 7 signal-conditioning portfolio for copper and optical interconnects, with initial sampling expected in Q4 2026. The company's PCIe 6 products generated over 50% of Q2 revenues with record Aries sales.

For Q3 2026, ALAB expects revenues between $540-560 million, representing ~40% sequential growth. The company faces competition from Marvell Technology and Credo Technology in the AI connectivity space.

Credo Technology (CRDO) is expanding its retimer portfolio with products like Blue Heron and Toucan, achieving record retimer revenue driven by AI infrastructure demand. The company faces competition from Astera Labs and Broadcom, which are also capitalizing on growing AI networking needs. CRDO trades at a premium valuation (P/S ratio of 13.56 vs. industry 5.14) and carries a Zacks Rank #3 (Hold).

Astera Labs (ALAB) has significantly outperformed the broader tech sector with a 117.8% year-to-date gain, driven by strong demand for its AI infrastructure and connectivity solutions, particularly its PCIe 6 products. The company reported record Q2 2026 revenues and provided strong Q3 guidance with expected sequential growth of 40%.

However, the stock trades at a premium valuation (22.66X forward P/S vs sector 6.18X), faces intensifying competition from players like Marvell Technology, and is experiencing rising operating expenses. Zacks rates ALAB as a Hold (#3 Rank).

The article compares two semiconductor stocks: Astera Labs, which provides AI connectivity solutions with explosive 115% revenue growth but faces customer concentration risk, and Arm, which licenses chip architecture with stable 22.8% growth and reliable royalty streams. The author recommends Astera Labs for growth-focused investors despite concentration risks, while Arm suits those preferring consistency.

Astera Labs (ALAB) declined 1.71% to $350.33, underperforming the broader market which gained 0.73%. Despite the daily drop, the stock has surged 26.02% over the prior period.

The company maintains a Zacks Rank #1 (Strong Buy) rating with strong earnings growth expectations: EPS projected at $1.19 (up 142.86% YoY) and revenue at $550.39 million (up 138.71% YoY). However, the stock trades at a premium Forward P/E of 89.69 versus the industry average of 19.59.

Allient Inc (ALNT) has significantly outperformed the Computer and Technology sector year-to-date, returning 108.6% compared to the sector average of 21.8%. The company holds a Zacks Rank #1 (Strong Buy) with improving analyst sentiment, as consensus earnings estimates have increased 10.8% in the past quarter. Astera Labs (ALAB) has also outperformed with a 115.1% return and similar Strong Buy rating.

Astera Labs (ALAB), a Zacks Rank #1 Strong Buy, develops semiconductor connectivity chips for AI data centers. The company has delivered consistent triple-digit earnings and revenue growth since 2024, beating analyst expectations every quarter. Investor Gavin Baker highlights ALAB's role as an irreplaceable bottleneck asset in AI infrastructure, with hyperscalers increasingly developing custom silicon and relying on ALAB's connectivity solutions.

The article compares two semiconductor companies: Arm, which licenses chip architecture used in billions of devices globally with strong profitability and low risk, and Credo Technology Group, which provides high-speed interconnects for AI data centers with explosive 205% revenue growth but higher customer concentration risk. The author recommends Credo for its superior growth trajectory despite Arm's defensible business model.

Marvell Technology (MRVL) has surged 220.5% YTD driven by strong AI-related data-center growth, with fiscal 2027 revenues expected to rise 45% and data-center revenues up 60%. However, the stock trades at a premium valuation (P/S of 14.85X vs. industry 5.25X) and faces significant headwinds from customer concentration, intense competition, and geopolitical risks. Analysts recommend a 'Hold' rating.

Arm and Credo Technology Group represent two different plays on AI infrastructure growth. Arm provides processor architecture for billions of devices with a durable royalty model and 22.8% revenue growth, while Credo offers high-speed connectivity solutions with explosive 205.7% revenue growth but faces customer concentration risk. The author recommends Credo for growth-focused investors despite higher risk, while Arm suits those seeking consistency.